Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide.
暂无分享,去创建一个
D. Wegmann | P. Gottlieb | A. Putnam | P. Crowe | Eric B. Johnson | P. Conlon | T. Motheral | S. Boehme | A. Gaur | N. Ling | A. Pahuja | D. Alleva | Li-Qin Jin